| Alexis Christine Smith, DO | |
|
10030 Gilead Rd Ste 300, Huntersville, NC 28078-7545 | |
| (704) 384-7972 | |
| (704) 384-7973 |
| Full Name | Alexis Christine Smith |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 13 Years |
| Location | 10030 Gilead Rd Ste 300, Huntersville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235428103 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Huntersville Medical Center | Huntersville, NC | Hospital |
| Novant Health Presbyterian Medical Center | Charlotte, NC | Hospital |
| Novant Health Matthews Medical Center | Matthews, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Presbyterian Hospital | 1153231907 | 359 |
| Novant Medical Group Inc | 1153234893 | 1996 |
News Archive
Apollo, the pioneer in clinical multimedia management solutions is introducing, and will be demonstrating integration of the ResolutionMD enterprise image viewer to Apollo EPMM (Enterprise Patient Multimedia Manager) at the upcoming RSNA 2015 annual meeting. This is a result of a previously announced alliance between Apollo and Calgary Scientific.
Though "[m]ost international support credited with the recent decline in malaria in Africa has been channeled to providing bednets, diagnostics and drugs, a Cuban company called Labiofam is marketing bacterial larvicides in Africa to help fight the disease," the Financial Times reports.
Synthes, Inc. (SWX: SYST.VX), a leading global medical device company in the orthopaedic trauma, spine, and cranio-maxillofacial markets, and Kensey Nash Corporation (Nasdaq: KNSY), a leading developer and manufacturer of innovative regenerative medicine products, today announced a strategic agreement for products developed from Kensey Nash's unique extracellular matrix (ECM) technology.
Stem cell therapy may restore cognition in patients with brain cancer who experience functional learning and memory loss often associated with radiation treatment, according to a laboratory study published in Cancer Research, a journal of the American Association for Cancer Research.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
› Verified 6 days ago
| Entity Name | Novant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366409492 PECOS PAC ID: 1153234893 Enrollment ID: O20031121000692 |
News Archive
Apollo, the pioneer in clinical multimedia management solutions is introducing, and will be demonstrating integration of the ResolutionMD enterprise image viewer to Apollo EPMM (Enterprise Patient Multimedia Manager) at the upcoming RSNA 2015 annual meeting. This is a result of a previously announced alliance between Apollo and Calgary Scientific.
Though "[m]ost international support credited with the recent decline in malaria in Africa has been channeled to providing bednets, diagnostics and drugs, a Cuban company called Labiofam is marketing bacterial larvicides in Africa to help fight the disease," the Financial Times reports.
Synthes, Inc. (SWX: SYST.VX), a leading global medical device company in the orthopaedic trauma, spine, and cranio-maxillofacial markets, and Kensey Nash Corporation (Nasdaq: KNSY), a leading developer and manufacturer of innovative regenerative medicine products, today announced a strategic agreement for products developed from Kensey Nash's unique extracellular matrix (ECM) technology.
Stem cell therapy may restore cognition in patients with brain cancer who experience functional learning and memory loss often associated with radiation treatment, according to a laboratory study published in Cancer Research, a journal of the American Association for Cancer Research.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
› Verified 6 days ago
| Entity Name | The Presbyterian Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053365817 PECOS PAC ID: 1153231907 Enrollment ID: O20040223001121 |
News Archive
Apollo, the pioneer in clinical multimedia management solutions is introducing, and will be demonstrating integration of the ResolutionMD enterprise image viewer to Apollo EPMM (Enterprise Patient Multimedia Manager) at the upcoming RSNA 2015 annual meeting. This is a result of a previously announced alliance between Apollo and Calgary Scientific.
Though "[m]ost international support credited with the recent decline in malaria in Africa has been channeled to providing bednets, diagnostics and drugs, a Cuban company called Labiofam is marketing bacterial larvicides in Africa to help fight the disease," the Financial Times reports.
Synthes, Inc. (SWX: SYST.VX), a leading global medical device company in the orthopaedic trauma, spine, and cranio-maxillofacial markets, and Kensey Nash Corporation (Nasdaq: KNSY), a leading developer and manufacturer of innovative regenerative medicine products, today announced a strategic agreement for products developed from Kensey Nash's unique extracellular matrix (ECM) technology.
Stem cell therapy may restore cognition in patients with brain cancer who experience functional learning and memory loss often associated with radiation treatment, according to a laboratory study published in Cancer Research, a journal of the American Association for Cancer Research.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
› Verified 6 days ago
| Entity Name | Knd Development 59 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619206133 PECOS PAC ID: 3678602802 Enrollment ID: O20100719000361 |
News Archive
Apollo, the pioneer in clinical multimedia management solutions is introducing, and will be demonstrating integration of the ResolutionMD enterprise image viewer to Apollo EPMM (Enterprise Patient Multimedia Manager) at the upcoming RSNA 2015 annual meeting. This is a result of a previously announced alliance between Apollo and Calgary Scientific.
Though "[m]ost international support credited with the recent decline in malaria in Africa has been channeled to providing bednets, diagnostics and drugs, a Cuban company called Labiofam is marketing bacterial larvicides in Africa to help fight the disease," the Financial Times reports.
Synthes, Inc. (SWX: SYST.VX), a leading global medical device company in the orthopaedic trauma, spine, and cranio-maxillofacial markets, and Kensey Nash Corporation (Nasdaq: KNSY), a leading developer and manufacturer of innovative regenerative medicine products, today announced a strategic agreement for products developed from Kensey Nash's unique extracellular matrix (ECM) technology.
Stem cell therapy may restore cognition in patients with brain cancer who experience functional learning and memory loss often associated with radiation treatment, according to a laboratory study published in Cancer Research, a journal of the American Association for Cancer Research.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexis Christine Smith, DO Po Box 60447, Charlotte, NC 28260-0447 Ph: (704) 384-7972 | Alexis Christine Smith, DO 10030 Gilead Rd Ste 300, Huntersville, NC 28078-7545 Ph: (704) 384-7972 |
News Archive
Apollo, the pioneer in clinical multimedia management solutions is introducing, and will be demonstrating integration of the ResolutionMD enterprise image viewer to Apollo EPMM (Enterprise Patient Multimedia Manager) at the upcoming RSNA 2015 annual meeting. This is a result of a previously announced alliance between Apollo and Calgary Scientific.
Though "[m]ost international support credited with the recent decline in malaria in Africa has been channeled to providing bednets, diagnostics and drugs, a Cuban company called Labiofam is marketing bacterial larvicides in Africa to help fight the disease," the Financial Times reports.
Synthes, Inc. (SWX: SYST.VX), a leading global medical device company in the orthopaedic trauma, spine, and cranio-maxillofacial markets, and Kensey Nash Corporation (Nasdaq: KNSY), a leading developer and manufacturer of innovative regenerative medicine products, today announced a strategic agreement for products developed from Kensey Nash's unique extracellular matrix (ECM) technology.
Stem cell therapy may restore cognition in patients with brain cancer who experience functional learning and memory loss often associated with radiation treatment, according to a laboratory study published in Cancer Research, a journal of the American Association for Cancer Research.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
› Verified 6 days ago
Dr. Temple V Day, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 16455 Statesville Rd, Huntersville, NC 28078 Phone: 704-896-2095 Fax: 704-896-0599 | |
Jason Anthony Carnes, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9615 Kincey Ave Ste 210, Huntersville, NC 28078 Phone: 704-489-3113 | |
Alexandria Atuahene Opata, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 16525 Holly Crest Ln Ste 230, Huntersville, NC 28078 Phone: 704-316-6360 Fax: 704-316-6361 | |
Dr. Tiona Kimisha Stephens, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 16224 Hollingbourne Rd, Huntersville, NC 28078 Phone: 954-593-1550 | |
Dr. Thomas P. Stern, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 16507 Northcross Dr, Suite F, Huntersville, NC 28078 Phone: 704-248-0000 Fax: 877-973-1761 | |
Dr. Yousuf Khan, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 16525 Holly Crest Lane, Suite 230, Huntersville, NC 28078 Phone: 704-316-6360 Fax: 704-316-6361 | |
Carly Rivet Hamlin, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 16455 Statesville Rd, Ste 360, Huntersville, NC 28078 Phone: 704-801-3300 |